APA

Banerji U., Sain N., Sharp S. Y., Valenti M., Asad Y., Ruddle R., Raynaud F., Walton M., Eccles S. A., Judson I., Jackman A. L. & Workman P. (2018). Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models. : Cancer chemotherapy and pharmacology.

Chicago

Banerji Udai, Sain Nivedita, Sharp Swee Y, Valenti Melanie, Asad Yasmin, Ruddle Ruth, Raynaud Florence, Walton Michael, Eccles Suzanne A, Judson Ian, Jackman Ann L and Workman Paul. 2018. Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models. : Cancer chemotherapy and pharmacology.

Harvard

Banerji U., Sain N., Sharp S. Y., Valenti M., Asad Y., Ruddle R., Raynaud F., Walton M., Eccles S. A., Judson I., Jackman A. L. and Workman P. (2018). Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models. : Cancer chemotherapy and pharmacology.

MLA

Banerji Udai, Sain Nivedita, Sharp Swee Y, Valenti Melanie, Asad Yasmin, Ruddle Ruth, Raynaud Florence, Walton Michael, Eccles Suzanne A, Judson Ian, Jackman Ann L and Workman Paul. Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models. : Cancer chemotherapy and pharmacology. 2018.